Market Research Logo

Leukemia & Lymphoma Society Inc - Strategic SWOT Analysis Review

Leukemia & Lymphoma Society Inc - Strategic SWOT Analysis Review

- provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

The Leukemia & Lymphoma Society Inc (LLS) is a voluntary health organization that focuses on funding research for identifying cure for blood cancer. The organization also assures access to treatments for blood cancer patients. Its offers patient support, health education, policy advocacy, and raises funds and funds for medical research. LLS’ provides treatment for various diseases, including leukemia, lymphoma, myelodysplastic syndromes, myeloproliferative neoplasms and myeloma. The organization works in collaboration with pharmaceutical and biotechnology companies, patients support services and advocates working for blood cancer patients. It has operations in the US and Canada. LLS is headquartered in Rye Brook, New York, the US.

Leukemia & Lymphoma Society Inc Key Recent Developments

Jan 08,2018: The Leukemia & Lymphoma Society Announces New Research Program for Deadly Blood Cancer
Dec 10,2017: Sequencing offers clues to progression toward multiple myeloma
Dec 06,2017: The Leukemia & Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer
Dec 06,2017: Study Uses Genetic Testing to Personalize Treatment for Deadly Blood Cancer
Dec 06,2017: The Leukemia Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note:Some sections may be missing if data is unavailable for the company.


Section 1 - About the Company 5
Leukemia & Lymphoma Society Inc - Key Facts 5
Leukemia & Lymphoma Society Inc - Key Employees 6
Leukemia & Lymphoma Society Inc - Key Employee Biographies 8
Leukemia & Lymphoma Society Inc - Major Products and Services 10
Leukemia & Lymphoma Society Inc - History 11
Leukemia & Lymphoma Society Inc - Company Statement 13
Leukemia & Lymphoma Society Inc - Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Leukemia & Lymphoma Society Inc - Business Description 15
R&D Overview 15
Leukemia & Lymphoma Society Inc - Corporate Strategy 16
Leukemia & Lymphoma Society Inc - SWOT Analysis 17
SWOT Analysis - Overview 17
Leukemia & Lymphoma Society Inc - Strengths 17
Leukemia & Lymphoma Society Inc - Weaknesses 18
Leukemia & Lymphoma Society Inc - Opportunities 19
Leukemia & Lymphoma Society Inc - Threats 20
Section 3 – Company’s Lifesciences Financial Deals and Alliances 21
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
Leukemia & Lymphoma Society Inc, Recent Deals Summary 23
Section 4 – Company’s Recent Developments 24
Jan 08, 2018: The Leukemia & Lymphoma Society Announces New Research Program for Deadly Blood Cancer 24
Dec 10, 2017: Sequencing offers clues to progression toward multiple myeloma 25
Dec 06, 2017: The Leukemia & Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer 26
Dec 06, 2017: The Leukemia Lymphoma Society Achieves New Milestones in Offensive Against Acute Myeloid Leukemia, Deadly Blood Cancer 28
Dec 06, 2017: Study Uses Genetic Testing to Personalize Treatment for Deadly Blood Cancer 30
Nov 21, 2017: The Leukemia & Lymphoma Society awards grant to Savoldo for immunotherapy research 31
Nov 20, 2017: LLS Funds $46 Million in New Research to Find Cures 32
Jun 28, 2017: Protocol First Selected by the Leukemia & Lymphoma Society for Beat AML Master Trial Initiative 35
Mar 23, 2017: Medidata’s Clinical Technology Platform Selected for Groundbreaking “Beat AML Master Trial” 36
Mar 16, 2017: LLS APPOINTS DR. GWEN NICHOLS, CHIEF MEDICAL OFFICER 37
Section 5 – Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
List of Tables
Leukemia & Lymphoma Society Inc, Key Facts 5
Leukemia & Lymphoma Society Inc, Key Employees 6
Leukemia & Lymphoma Society Inc, Key Employee Biographies 8
Leukemia & Lymphoma Society Inc, Major Products and Services 10
Leukemia & Lymphoma Society Inc, History 11
Leukemia & Lymphoma Society Inc, Subsidiaries 14
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 22
Leukemia & Lymphoma Society Inc, Recent Deals Summary 23
List of Figures
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 21
Leukemia & Lymphoma Society Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 22

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report